InvestorsHub Logo
Followers 21
Posts 3555
Boards Moderated 0
Alias Born 12/18/2019

Re: $5.95akadawson-m post# 211578

Friday, 07/08/2022 12:55:14 PM

Friday, July 08, 2022 12:55:14 PM

Post# of 232503
mTNBC trial results are deceptive -- FDA rejected FTD application and the SEC and DOJ are investigating the company's trial result reporting -- likely for stock fraud. Combining recurrent mTNBC compassionate data with naïve trial data is not clinically valid. Then comparing the combination against an approved drug with only recurrent results is deceptive.

Company has no cash to do any more trials so it is unlikely that it will go anywhere.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News